Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 8.29 is 33% below its 5-year average of 12.40, near the low end of its 5-year range (8.29–25.13).
As of the fiscal period ended Tuesday, June 30, 2026. 15.94% below its 12-month average of 9.87.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.29.
QUICK RATIO (ACID-TEST)
8.29
QUICK RATIO (ACID-TEST) AVG TTM
9.87
QUICK RATIO (ACID-TEST) AVG 3Y
10.86
QUICK RATIO (ACID-TEST) AVG 5Y
12.40
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-15.94%
CURRENT VS 3Y AVG
-23.60%
CURRENT VS 5Y AVG
-33.10%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+147.22%
vs the sector median at left
Market Cap
$5.06B
Quick Ratio (Acid-Test)
1.85
TTM Avg
1.98
3Y Avg
1.97
5Y Avg
1.88
Market Cap
$5.07B
Quick Ratio (Acid-Test)
2.79
TTM Avg
2.90
3Y Avg
2.74
5Y Avg
2.21
Market Cap
$5.09B
Quick Ratio (Acid-Test)
7.02
TTM Avg
8.28
3Y Avg
8.59
5Y Avg
7.77
Market Cap
$4.84B
Quick Ratio (Acid-Test)
38.51
TTM Avg
25.63
3Y Avg
37.00
5Y Avg
29.64
Market Cap
$4.83B
Quick Ratio (Acid-Test)
2.74
TTM Avg
2.74
3Y Avg
3.13
5Y Avg
4.87
Market Cap
$4.78B
Quick Ratio (Acid-Test)
26.10
TTM Avg
14.27
3Y Avg
14.23
5Y Avg
14.47
Market Cap
$5.19B
Quick Ratio (Acid-Test)
13.57
TTM Avg
9.78
3Y Avg
9.13
5Y Avg
11.38
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Erasca, Inc. (ERAS) | $4.96B | 8.29 | 9.87 | 10.86 | 12.40 |
| Waystar Holding Corp. (WAY)vs › | $5.06B | 1.85 | 1.98 | 1.97 | 1.88 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 2.79 | 2.90 | 2.74 | 2.21 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.09B | 7.02 | 8.28 | 8.59 | 7.77 |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.84B | 38.51 | 25.63 | 37.00 | 29.64 |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.83B | 2.74 | 2.74 | 3.13 | 4.87 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.78B | 26.10 | 14.27 | 14.23 | 14.47 |
| Cogent Biosciences, Inc. (COGT)vs › | $5.19B | 13.57 | 9.78 | 9.13 | 11.38 |
| Doximity, Inc. (DOCS)vs › | $5.20B | 6.08 | 6.53 | 6.56 | 6.07 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.73B | 6.95 | 6.77 | 6.23 | 10.87 |
Quick Ratio
8.29
Excludes inventory
Current Ratio
8.29
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 8.29 |
| 2026-03-31 | 9.52 |
| 2025-12-31 | 10.04 |
| 2025-09-30 | 10.45 |
| 2025-06-30 | 11.04 |
| 2025-03-31 | 12.35 |
| 2024-12-31 | 9.84 |
| 2024-09-30 | 11.00 |
| 2024-06-30 | 16.79 |
| 2024-03-31 | 10.14 |
| 2023-12-31 | 12.26 |
| 2023-09-30 | 11.45 |
| 2023-06-30 | 13.90 |
| 2023-03-31 | 15.59 |
| 2022-12-31 | 9.13 |
| 2022-09-30 | 13.21 |
| 2022-06-30 | 17.09 |
| 2022-03-31 | 18.86 |
| 2021-12-31 | 16.02 |
| 2021-09-30 | 25.13 |
| 2021-06-30 | 11.01 |
| 2021-03-31 | 19.11 |
| 2020-12-31 | 8.77 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
